ORIC shareholders elect two Class II directors and ratify KPMG as auditor

Oric Pharmaceuticals, Inc.

Steven L. Hoerter and Angie You, Ph.D. elected as Class II directors until 2025 annual meeting.
Hoerter received 30,420,083 for, 21,252 withheld, 3,427,848 broker non-votes.
Angie You received 30,420,703 for, 20,632 withheld, 3,427,848 broker non-votes.
KPMG LLP ratified as independent auditor for FY2022 with 33,863,053 for, 6,025 against, 105 abstain.
Meeting held June 17, 2022 with 85.87% of outstanding shares represented.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.